Tissue plasminogen activator (tPA) and urokinase plasminogen activator (uPA) are known to activate pro-enzyme forms of MMP-2 and MMP-9 to active forms [37,38] and tPA and uPA have been proposed as markers for breast cancer progression [39,40]. This evidence concerns the gene PLAT and breast carcinoma.